Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesmilifene plus Docetaxel in Metastatic Breast Cancer
NCT00364195Phase 2Completed
- Sponsor
- YM BioSciences
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tesmilifene in breast cancer, sponsored by YM BioSciences. Started Jun 2006; status: completed.
02
Drugs
tesmilifene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00364195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364195.